ArticleScientific reports2025
Modulating depressive-like behaviors, memory impairment, and oxidative stress in chronic stress rat model using visible light therapy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Semaglutide Attenuates Type 2 Diabetes-Induced Neurotoxicity by Modulating Neuroinflammation, Oxidative Stress, and Neuroapoptosis.Life (Basel, Switzerland) · 2026Article
- Article
- From Stress to Neurodegeneration: A New Look at the Pathogenesis of Parkinson's Disease.Biomedicines · 2026Review
- Baicalin Alleviates Chronic Restraint Stress-Induced Depression-like Behavior by Suppressing ROS/HAntioxidants (Basel, Switzerland) · 2026Article
- Neuroprotective Effects of C-Phycocyanin in Chronic Unpredictable Mild Stress-Exposed Rats: Regulation of Neuroinflammation and CREB/BDNF Signaling.Neurochemical research · 2026Article
- Microbiota-derived metabolites and cognitive dysfunction in dialysis patients: mechanisms and targeted therapeutic strategies.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Chronic stress has been linked to significant cognitive impairments, which are exacerbated by oxidative stress and neuronal damage in brain regions such as the hippocampus and prefrontal cortex. This study investigates the therapeutic effects of different visible light wavelengths (white, red, green, and blue) on cognitive dysfunction and oxidative stress in a chronic unpredictable mild stress (CUMS)-induced rat model using stressors such as cold-water swimming, tail pinching, food and water deprivation, cage tilting, shaking, continuous illumination, wet cages, heat stress, and restraint. Sixty male Wistar rats were divided into control, CUMS, and light-exposure groups. The light-exposed groups received daily exposure to white (3000 lx), red (650 nm, 1300 lx), green (530 nm, 1300 lx), or blue (460 nm, 1300 lx) light for four hours over four weeks. Behavioral assessments were conducted to evaluate memory and depression-like behaviors. Biochemical analyses were performed to measure oxidative stress markers, acetylcholinesterase (AChE) activity, and serum corticosterone levels. Results showed that chronic stress significantly impaired cognitive function, increased oxidative stress, elevated AChE activity, and serum corticosterone level. Red light exposure had no significant effect on any of the evaluated parameters. However, Light exposure, particularly blue light, mitigated these effects by reducing reactive oxygen species (ROS), malondialdehyde (MDA), and nitrite levels, while enhancing total antioxidant capacity (TAC), superoxide dismutase (SOD) activity, and glutathione (GSH). Behavioral outcomes also improved, with increased memory performance and reduced depressive behaviors in light-treated groups. Histological analyses revealed decreased neuronal damage in the hippocampus and prefrontal cortex following light therapy. These findings suggest that visible light exposure, especially blue light, may serve as a promising non-invasive intervention for stress-induced cognitive impairments by reducing oxidative stress and neuronal damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.